StonvexLoading…
StonvexStonvexStonvexCore line items from EPAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-08-31 | Annual 2024 2024-08-31 | Annual 2023 2023-08-31 | Annual 2022 2022-08-31 |
|---|---|---|---|---|
Revenue | $616.90M | $589.51M | $598.20M | $571.22M |
Operating Income | $133.47M | $121.59M | $83.92M | $30.66M |
Net Income | $92.75M | $85.75M | $46.56M | $15.69M |
EPS (Diluted) | $1.70 | $1.56 | $0.82 | $0.26 |
Total Assets | $827.87M | $777.33M | $762.60M | $757.31M |
Total Liabilities | $394.17M | $385.35M | $435.98M | $438.70M |
Cash & Equivalents | $151.56M | $167.09M | $154.41M | $120.70M |
Free Cash Flow OCF − CapEx | $91.94M | $69.91M | $68.20M | $43.32M |
Shares Outstanding | 54.48M | 54.86M | 57.12M | 59.91M |